CAMBRIDGE, Massachusetts, July 24 [Category: Biology] -- The Massachusetts Biotechnology Council issued the following statement on July 23, 2026, by CEO Kendalle Burlin O'Connell:

* * *

CEO Innovation Policy Update 07.23.26

Several announcements this week made plain that maintaining U.S. leadership in biotechnology is a top administration priority, and that AI is the tool it intends to use to secure it. Across OSTP, HHS, and FDA, the same themes recurr . . .

Click here for more information about our products